d-Pinitol Improves Diabetic Sarcopenia by Regulation of the Gut Microbiome, Metabolome, and Proteome in STZ-Induced SAMP8 Mice
- 14 June 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (25) , 14466-14478
Abstract
D-Pinitol (DP) is primarily found in Vigna sinensis, which has been shown to have hypoglycemic and protective effects on target organs. However, the mechanism of DP in treating diabetic sarcopenia (DS) is still unclear. To explore the underlying mechanism of DS and the protective targets of DP by high-throughput analysis of 16S rRNA gene, metabolome, and the proteome. Streptozotocin-induced SAMP8 mice were intragastrically administrated DP (150 mg/kg) for 8 weeks. Fecal 16S rRNA gene sequencing and gastrocnemius muscle metabolomic and proteomic analyses were completed to investigate the gut-muscle axis interactions. DP significantly alleviated the muscle atrophy in diabetic mice. Dysfunction of the gut microbiota was observed in the DS mice. DP significantly reduced the Parabacteroides, Akkermansia, and Enterobacteriaceae, while it increased Lachnospiraceae_NK4A136. Metabolome and proteome revealed that 261 metabolites and 626 proteins were significantly changed in the gastrocnemius muscle of diabetic mice. Among these, DP treatment restored 44 metabolites and 17 proteins to normal levels. Functional signaling pathways of DP-treated diabetic mice included nucleotide metabolism, beta-alanine, histidine metabolism, ABC transporters, and the calcium signaling pathway. We systematically explored the molecular mechanism of DS and the protective effect of DP, providing new insights that may advance the treatment of sarcopenia.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2021MH376)
This publication has 46 references indexed in Scilit:
- Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidationJournal of Cachexia, Sarcopenia and Muscle, 2023
- Milk protects against sarcopenic obesity due to increase in the genus Akkermansia in faeces of db/db miceJournal of Cachexia, Sarcopenia and Muscle, 2023
- 5′-CMP and 5′-UMP alleviate dexamethasone-induced muscular atrophy in C2C12 myotubesBiochemistry and Biophysics Reports, 2023
- Role of the Gut Microbiome in Skeletal Muscle Physiology and PathophysiologyCurrent Osteoporosis Reports, 2022
- Diabetic sarcopenia: metabolic and molecular appraisalActa Diabetologica, 2022
- Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 miceJournal of Cachexia, Sarcopenia and Muscle, 2021
- Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implicationsJournal of Cachexia, Sarcopenia and Muscle, 2021
- Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiomeJournal of Cachexia, Sarcopenia and Muscle, 2021
- Phosphoproteomics analysis of diabetic cardiomyopathy in aging‐accelerated mice and effects of D‐pinitolProteomics – Clinical Applications, 2021
- Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7Journal of Cachexia, Sarcopenia and Muscle, 2021